Remove Animal Testing Remove Drug Research Remove Laboratories
article thumbnail

Time for change: non-human primates in drug research

Drug Target Review

This scarcity disrupts research timelines and limits the ability to replicate results across studies. The FDA’s new roadmap In April 2025, the FDA announced a major regulatory shift with its plan to phase out the requirement for animal testing in the development of monoclonal antibodies and other drugs, when scientifically appropriate.

article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7 billion in 2022 and is projected to reach US$10.2

article thumbnail

Origins of the Lab Mouse

Codon

The early supply of mice for research depended on a late-19th century community of hobbyists—fanciers—who collected, bred, and sold unusual mice varieties. ” Abbie Lathrop was a mouse fancier whose animals were later used to develop the C57Bl/6 strain that is now widespread in the biomedical sciences.